Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $48,900 - $105,600
-30,000 Reduced 47.54%
33,100 $55,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $46,063 - $235,994
63,100 New
63,100 $196,000
Q1 2022

May 16, 2022

SELL
$2.83 - $8.69 $28,300 - $86,900
-10,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.31 - $14.92 $83,100 - $149,200
10,000 New
10,000 $83,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.